3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
29
Rectal Neoplasms
20
Colonic Neoplasms
20
Head and Neck Neoplasms
14
Stomach Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
12
Breast Neoplasms
11
Esophageal Neoplasms
9
Adenocarcinoma Of Esophagus
9
Pancreatic Neoplasms
8
Anus Neoplasms
8
Anal Canal Carcinoma
6
Urinary Bladder Neoplasms
4
Uterine Cervical Neoplasms
3
Neoplasm Metastasis
3
Esophageal Squamous Cell Carcinoma
3
Squamous Intraepithelial Lesions
2
Hepatoblastoma
2
HIV Infections
2
Carcinoma, Hepatocellular
2
Tongue Neoplasms
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Radiation Injuries
1
Papillomavirus Infections
1
Pancreatic Adenocarcinoma
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Metastatic Small Intestinal Adenocarcinoma
1
Metastatic Pancreatic Adenocarcinoma
1
Interventions
Radiotherapy, Intensity-Modulated
3
Polymerase Chain Reaction
3
Cisplatin
3
Watchful Waiting
2
Light Coagulation
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cetuximab
2
Restraint, Physical
1
Platinum
1
Paclitaxel
1
Observation
1
Laser Therapy
1
Independent Medical Evaluation
1
Imiquimod
1
Histological Techniques
1
Fluorouracil
1
Flow Cytometry
1
Carboplatin
1
Biopsy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Papillomavirus Infections
×
Fluorouracil
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts